FDA approves Aurobindo’s Micardis HCT generic

1/20/2017

SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Micardis HCT (telmisartan and hydrochlorothiazide) tablets, the company announced Friday. 


 


The drug is indicated to treat hypertension and had a market size of $81.9 million for the 12 months ended November 2016, according to QuintilesIMS data.  


 


Aurobindo’s generic will be available in dosage strengths of 40 mg telmistartan/12.5 mg hydrochlorothiazide, 80 mg telmisartan/12.5 mg hydrochlorothiazide and 8- mg telmisartan/25 mg hydrochlorothiazide. 


 

X
This ad will auto-close in 10 seconds